All stock lists
Savara Inc (NASDAQ:SVRA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
4.34+0.12 (+2.91%)
Insider Score
––Not scored
SVRA Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
SVRA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 66.00 K | 40.00 K | 20.59 M | 385.00 K | 905.00 K |
| Gross Profit | 0.00 | -66.00 K | -40.00 K | -20.59 M | -385.00 K | -905.00 K |
| SG&A Expense | 18.99 M | 15.53 M | 12.53 M | 9.63 M | 10.65 M | 9.25 M |
| R&D Expense | 21.95 M | 23.40 M | 20.90 M | 20.59 M | 20.75 M | 19.16 M |
| Operating Expenses | 40.97 M | 38.92 M | 33.39 M | 9.66 M | 31.05 M | 27.53 M |
| Operating Income | -40.97 M | -38.99 M | -33.43 M | -30.25 M | -31.44 M | -28.43 M |
| Pretax Income | -40.23 M | -37.28 M | -32.24 M | -29.56 M | -30.40 M | -26.64 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -40.23 M | -37.28 M | -32.24 M | -29.56 M | -30.40 M | -26.64 M |
| EPS (Basic) | -0.16 | -0.15 | -0.13 | -0.14 | -0.14 | -0.12 |
| EPS (Diluted) | -0.16 | -0.15 | -0.13 | -0.14 | -0.14 | -0.12 |
| Shares Outstanding | 253.57 M | 253.28 M | 222.39 M | 216.46 M | 216.43 M | 216.15 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.